Neuberger Berman Group LLC raised its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 6.4% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 660,598 shares of the semiconductor company’s stock after acquiring an additional 39,957 shares during the quarter. Neuberger Berman Group LLC owned approximately 0.36% of Synopsys worth $325,932,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors have also made changes to their positions in the business. Alpine Bank Wealth Management lifted its position in shares of Synopsys by 89.3% during the 3rd quarter. Alpine Bank Wealth Management now owns 53 shares of the semiconductor company’s stock worth $26,000 after buying an additional 25 shares during the last quarter. TFC Financial Management Inc. lifted its position in Synopsys by 1,250.0% in the third quarter. TFC Financial Management Inc. now owns 54 shares of the semiconductor company’s stock valued at $27,000 after acquiring an additional 50 shares during the last quarter. Millstone Evans Group LLC purchased a new stake in Synopsys in the third quarter valued at $27,000. SOA Wealth Advisors LLC. acquired a new position in Synopsys in the third quarter valued at $28,000. Finally, McIlrath & Eck LLC acquired a new position in Synopsys in the third quarter valued at $29,000. Institutional investors and hedge funds own 85.47% of the company’s stock.
Synopsys Trading Down 1.1%
Shares of SNPS stock opened at $437.41 on Friday. The business’s fifty day moving average price is $466.71 and its 200 day moving average price is $470.69. Synopsys, Inc. has a 1-year low of $365.74 and a 1-year high of $651.73. The firm has a market capitalization of $83.79 billion, a PE ratio of 67.92, a P/E/G ratio of 3.60 and a beta of 1.15. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.36 and a quick ratio of 1.26.
Analyst Ratings Changes
A number of analysts recently issued reports on SNPS shares. Piper Sandler decreased their target price on Synopsys from $520.00 to $430.00 and set a “neutral” rating for the company in a research report on Thursday, February 26th. Weiss Ratings restated a “hold (c)” rating on shares of Synopsys in a research note on Thursday, January 22nd. Wall Street Zen raised shares of Synopsys from a “sell” rating to a “hold” rating in a report on Saturday, December 13th. Zacks Research raised Synopsys from a “strong sell” rating to a “hold” rating in a report on Monday, November 10th. Finally, HSBC cut Synopsys from a “buy” rating to a “hold” rating and set a $455.00 price target on the stock. in a research report on Friday, February 20th. Eight equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Synopsys has an average rating of “Hold” and an average target price of $531.00.
Get Our Latest Report on Synopsys
Insider Activity
In related news, CFO Shelagh Glaser sold 3,657 shares of the firm’s stock in a transaction dated Friday, December 19th. The shares were sold at an average price of $460.77, for a total value of $1,685,035.89. Following the completion of the sale, the chief financial officer owned 17,842 shares in the company, valued at $8,221,058.34. This trade represents a 17.01% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Janet Lee sold 250 shares of the business’s stock in a transaction dated Monday, January 12th. The stock was sold at an average price of $530.00, for a total transaction of $132,500.00. Following the sale, the insider directly owned 11,959 shares in the company, valued at approximately $6,338,270. This represents a 2.05% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 4,157 shares of company stock valued at $1,945,036 in the last quarter. Company insiders own 0.56% of the company’s stock.
About Synopsys
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Articles
- Five stocks we like better than Synopsys
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- What a Former CIA Agent Knows About the Coming Collapse
- Unlocked: Elon Musk’s Next Big IPO
- Elon Musk already made me a “wealthy man”
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
